№ lp_1_2_53896
File format: docx
Character count: 5638
File size: 70 KB
Year:
2016
Region / City:
Wales
Topic:
Vaccination, Immunosuppression
Document Type:
Medical/Health Advisory
Organization:
NHS Wales
Author:
Dr Chris Jones
Target Audience:
Healthcare professionals, General practitioners, Paediatricians, Oncologists, Rheumatologists, Immunologists, Nurses, Pharmacists, Medical Directors
Period of Validity:
Not specified
Approval Date:
4 May 2016
Modification Date:
Not specified
Contextual Description:
Medical advisory document warning healthcare professionals about the risks of live attenuated vaccines for immunosuppressed individuals, especially neonates and elderly patients.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2025
Region / city:
United Kingdom
Topic:
Immunization, Influenza Vaccine
Document Type:
Addendum
Organization / Institution:
UK Health Security Agency (UKHSA)
Author:
Suki Hunjunt, Alex Allen, Greta Hayward
Target Audience:
Health professionals, Immunization Programs
Effective Period:
1 September 2025 - 1 April 2026
Approval Date:
6 August 2025
Modification Date:
23 July 2025
Background:
Live attenuated influenza vaccine nasal spray suspension (Fluenz®) updated formula
Contextual Description:
Addendum to UKHSA PGD v15.0 detailing updates to the influenza vaccine composition and active strains.
Year:
2025
Region / city:
England
Topic:
Influenza Vaccination
Document Type:
Patient Group Direction (PGD)
Authority / institution:
UK Health Security Agency (UKHSA)
Author:
Suki Hunjunt, Jamie Lopez-Bernal, Greta Hayward
Target Audience:
Healthcare practitioners, immunisation staff
Period of validity:
From 1 September 2025 to 1 April 2026
Approval Date:
1 July 2025
Amendment Date:
25 June 2025
Year:
2026
Region / Institution:
Guangdong Medical University, China; Shenzhen Bay Laboratory, China
Subject:
Pharmacology, Cardiology, Oxidative Stress
Document Type:
Research Article, Supplementary Material
Authors:
Yuwei Peng, Yishan Guo, Xinyi Yang, Yulan Liu, Xun Xu, Junhong Chen, Xueyi Liu, Zhiqiang Yu, Dudu Wu, Zhi Chen
Corresponding Author:
Dudu Wu, Zhi Chen
Methodology:
NMR Spectroscopy (1H NMR, 13C NMR)
Target Audience:
Researchers in biomedical sciences and pharmacology
Supplementary Data:
Figures S1–S12 showing NMR spectra of IDE derivatives
Affiliation:
School of Pharmacy, Guangdong Medical University; Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory
Email Contact:
[email protected]
Year:
2026
Organism:
Histomonas meleagridis
Strain:
Virulent (25), Attenuated (303)
Method:
SWATH MS
Protein categories:
Peptidases, Hypothetical proteins, Cytoskeleton, Metabolic processes, Calcium-binding, Lipid metabolism, Protein synthesis, Carbohydrate metabolism, Membrane trafficking, Vesicle fusion, Signaling
Data type:
Mass-to-charge ratio values and peptide sequences
Target audience:
Researchers in proteomics and microbiology
Period of study:
Not specified
Date of compilation:
2026
Year:
2025
Region / City:
West Glamorgan
Subject:
Integrated Discharge Strategy, Hospital Discharge, Patient Care
Document Type:
Report
Institution:
West Glamorgan Regional Partnership Board
Author:
Emily Warren, Helen St John
Target Audience:
Health and Social Care Professionals, Policy Makers
Period of Action:
May 2024 - March 2025
Approval Date:
28 January 2025
Date of Amendments:
Not specified
Context:
A report detailing the progress of the Integrated Discharge Strategy (IDS), which aims to improve discharge planning and reduce patient delays at hospitals.
Year:
2023
Region / City:
Temple University Hospital, USA
Subject:
EEG, Neuroscience, Medical Research
Document Type:
Research Article
Institution:
Temple University
Author:
Multiple contributors
Target Audience:
Researchers, Medical Professionals
Period of Data Collection:
14 years
Approval Date:
Not specified
Date of Latest Update:
Not specified
Year:
2023
Region / City:
Southern Health
Topic:
Medical guidelines for opioid patch use and syringe driver medication administration
Document type:
Clinical Protocol
Organization:
HHFT (Southern Health NHS Foundation Trust)
Author:
Southern Health NHS Foundation Trust
Target Audience:
Healthcare professionals involved in palliative care and medication administration
Period of validity:
April 2023
Date of approval:
April 2023
Date of changes:
April 2023
Year:
2026
Region / city:
United States
Topic:
Health assessment and risk management for potential infectious disease exposure
Document type:
Risk assessment form
Organization:
Centers for Disease Control and Prevention (CDC)
Author:
Centers for Disease Control and Prevention (CDC)
Target audience:
Healthcare providers, public health officials
Period of validity:
Ongoing
Approval date:
2026
Date of changes:
N/A
Description:
A health risk assessment form used by CDC to assess potential exposure to [SAMPLE VHF] and guide public health responses at points of entry.
Year:
2023
Region / city:
United Kingdom
Topic:
Healthcare, Infection Control
Document Type:
Standards
Organization:
National Health Service (NHS)
Author:
NHS Infection Prevention and Control (IP&C) Committee
Target Audience:
Healthcare Providers, Clinical Staff, Infection Control Teams
Period of validity:
Ongoing
Approval Date:
2023-01-01
Amendment Date:
2023-01-01
Year:
2023
Region / City:
Australia
Subject:
Healthcare, Medicare Benefits Schedule
Document Type:
Factsheet
Organization:
Department of Health and Aged Care
Author:
Department of Health and Aged Care
Target Audience:
Healthcare providers, referrers, private health insurance stakeholders
Effective Date:
1 November 2022
Amendment Date:
1 March 2023
Sample size:
10378 patients
Medical condition:
Prostate cancer
Subgroups:
Clinically significant prostate cancer (csPCa), Insignificant prostate cancer (Ins-PCa), All prostate cancer (PCa)
Variables analyzed:
Age, PSA level, Prostate volume (PV), PSA density (PSAD), PI-RADS score
Age categories:
<50; 50–60; 60–70; 70–80; ≥80 years
PSA categories:
<10; 10–20; 20–50; 50–100; ≥100 ng/mL; Unknown
Prostate volume categories:
<30; 30–40; 40–60; ≥60 ml; Unknown
PSA density categories:
<0.1; 0.1–0.15; 0.15–0.2; ≥0.2; Unknown
Imaging classification system:
PI-RADS (Prostate Imaging-Reporting and Data System)
Data type:
Quantitative clinical characteristics with counts and percentages
Medical field:
Urology / Oncology
Document type:
Statistical table of clinical study data
Year:
2026
Region:
International
Topic:
Exercise interventions and memory outcomes in depression
Document type:
Systematic review and meta-analysis
Authors:
Halappa, Lavretsky, Khatri, Imboden, Hoffman, Krogh, Oertel-Knochel, Bushert, Zheng, Sharma, Chen, Zhang
Target population:
Clinically diagnosed patients with depression
Study design:
Randomized controlled trials
Cognitive domains assessed:
Verbal memory, spatial memory
Intervention types:
Yoga, aerobic exercise, strength training, TMS
Duration of interventions:
4–16 weeks
Outcome measures:
RAVLT, DSTF, DSTB, WMS, BSRT, RCFT, VLMT
Methodological approach:
Leave-one-out meta-analysis, RoB 2.0 risk assessment, GRADE certainty rating
Year:
2021-2022
Region / city:
Abuja, Nigeria
Theme:
Traumatic brain injury, Clinical research
Document type:
Research article
Institution:
National Hospital Abuja
Author:
Not specified
Target audience:
Medical professionals, researchers
Period of validity:
N/A
Approval date:
N/A
Date of amendments:
N/A